$Kintara Therapeutics(KTRA.US)$  Bullish Buy of 220k shares🚀

$Cassava Sciences(SAVA.US)$  Very Bullish 🚀An Open Letter from Executive Chairman Rick Barry to the Cassava Community:
Shareholders, Employees, Principal Investigators, Patients and their Loved Ones
´ Our ultimate goal is to develop an effective treatment for a patient population that has little hope and few therapeutic options.
Our first Phase 3 trial is expected to read out by December 2024, with 804 patients randomized 1:1 between simufilam and placebo. The second Phase 3 trial of 1,125 patie...

$Cassava Sciences(SAVA.US)$ Good 44k share purchase of SAVA

$Cassava Sciences(SAVA.US)$ Lots of manipulation as Max pain for options turned to $11 for tomorrow. On Another note, someone loaded up 85k shares at $11 now

$Cassava Sciences(SAVA.US)$The continuous statements that shorts made  and keep making  since 2021 on twitter should be considered defamatory  in court as these are  made every single day with the purpose of destroying the company reputation and profiting from short selling the stock, knowing that those statements on a daily basis will create doubt. It is also arrogant of them  to continue to keep making the same statements while in litigation.  Shouldn't there be a gag oder in place, judge?  Th...

$Cassava Sciences(SAVA.US)$These shorts are full of evil agenda. Alzheimer's is a debilitating disease and the longer it is untreated, you get worse very fast to death. Many  patients got better , were safe and wanted to stay on the drug throughout phase 3.  People who have AD or families with AD would not let their loved ones continue to take a sugar pill  or something that doesn't work more than 6 months.  It obviously has many benefits  and these shorts on twitter, HF, Bredt Rapport & BIK don...

$Cassava Sciences(SAVA.US)$ some hedge funds manipulate stock prices on key reporting dates.

$Cassava Sciences(SAVA.US)$ The benefits of repairing misfolded protein ’Sava: Simufilam’ as opposed to removing amyloid plaques other company drugs keep doing that causes brain bleeding, brain swelling and some, death.

$Cassava Sciences(SAVA.US)$ Crucial conflict of Interest details between Rapport Therapeutics founder that has co-founder on NIH Board and short Selling SAVA Stock. In summary, the conflicts of interest stem from Bredt’s dual role in financially benefiting from Cassava's potential failure (through short selling) and professionally advancing a competing Alzheimer’s treatment, which could be seen as motivations for filing the Citizen's Petition against Cassava Sciences.

$Cassava Sciences(SAVA.US)$ The conflict of interest or alleged corruption from those opposing Cassava Sciences is very easy to trace. People panic on clickbait FUD headlines without doing their research. Rapport Company that is against SAVA, founder and chairman Steve Paul is also chairman of the board of the foundation for the NIH. His co-founder David Bredt, is the One who made that Citizen's Petition and using a lot of the same mechanisms as SAVA with their company but claim that he never in...